Compare YAAS & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YAAS | POM |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | China | China |
| Employees | 22 | N/A |
| Industry | Computer Software: Prepackaged Software | Other Specialty Stores |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 13.5M |
| IPO Year | N/A | N/A |
| Metric | YAAS | POM |
|---|---|---|
| Price | $0.93 | $0.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 70.4K | ★ 18.2M |
| Earning Date | 01-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.06 |
| 52 Week High | $7.00 | $6.43 |
| Indicator | YAAS | POM |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 35.96 |
| Support Level | $0.90 | $0.10 |
| Resistance Level | $1.09 | $0.44 |
| Average True Range (ATR) | 0.08 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 47.98 | 4.61 |
Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.